MEN1 and colorectal carcinoma: The Menin-KMT2A/B complex maintains a fine balance between activating H3K4me3 and repressive H3K27me3 at bivalent promoters; loss or inhibition of Menin disrupts this equilibrium, leading to aberrant gene activation and CRC progression [87].